Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy.
Inflammatory immune-related adverse events are known complications of immunotherapy, particularly checkpoint inhibitors.
APA
Farazmand C, Attaseth P, Zhuang H (2026). Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy.. Clinical nuclear medicine, 51(1), 57-60. https://doi.org/10.1097/RLU.0000000000006096
MLA
Farazmand C, et al.. "Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy.." Clinical nuclear medicine, vol. 51, no. 1, 2026, pp. 57-60.
PMID
41365510
Abstract
Inflammatory immune-related adverse events are known complications of immunotherapy, particularly checkpoint inhibitors. A 16-year-old girl with metastatic melanoma, treated with nivolumab, dabrafenib, and trametinib, presented with abdominal pain and vomiting. Initial CT suggested metastases, showing mesenteric stranding and targetoid lesions. FDG PET/CT confirmed increased FDG uptake in the same region, but subsequent MRI and follow-up findings pointed to mesenteric panniculitis.
MeSH Terms
Humans; Female; Positron Emission Tomography Computed Tomography; Fluorodeoxyglucose F18; Adolescent; Melanoma; Diagnosis, Differential; Immunotherapy; Neoplasm Metastasis; Panniculitis, Peritoneal